This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Thermo Fisher Scientific Showcases Technologies To Improve Accuracy And Productivity In The Clinical Laboratory

Stocks in this article: TMO

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today showcased its comprehensive offering of specialty diagnostics products and analytical instruments designed to improve accuracy and productivity in clinical applications. The Thermo Scientific solutions are on display in booth 5140 during the Clinical Lab Expo at the American Association for Clinical Chemistry (AACC) conference, being held at the George R. Brown Convention Center in Houston from July 30 - August 1.

“Clinical laboratories are playing an ever-increasing role in supporting the diagnosis and monitoring of disease,” said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. “Our goal is to develop new technologies and diagnostic tests that enable physicians to deliver better patient care at a lower cost.”

Better Tests for Informed Clinical Decisions

Thermo Fisher announced that its new Thermo Scientific QMS Tacrolimus immunoassay, unveiled at AACC last year, has received 510(k) clearance by the U.S. Food and Drug Administration. The liquid, ready-to-use immunoassay measures levels of tacrolimus on automated clinical chemistry analyzers, including the bench-top Thermo Scientific Indiko analyzer, to improve the quality of life for kidney, liver, and heart transplant patients.

The company also marked the debut of another FDA-cleared product, the Thermo Scientific MAS Omni•CARDIO controls, an assayed control serum comprising a combination of cardiac and associated critical markers for use in clinical laboratories to monitor assay conditions. The single test eliminates the need for separate quality control measures between tests and provides rapid results.

Leading Portfolio of Tools for Research Use Only

The new Thermo Scientific Sorvall ST 8 centrifuge reduces potential bottlenecks in the laboratory through its flexible, user-friendly design. The small bench-top centrifuge offers easy rotor exchange, an ability to spin several types of tubes simultaneously and integration with other tools, including microplates.

This year also marks the AACC introduction of Thermo Fisher’s landmark new offerings in chromatography and mass spectrometry. Its Thermo Scientific Prelude SPLC sample preparation and liquid chromatography system, combined with the new workhorse Thermo Scientific TSQ Endura triple-stage quadrupole mass spectrometer, provides the performance necessary for analysis of target compounds in complex biological matrices. The resulting workflow is easy to manage making LC-MS more widely accessible in clinical research laboratories.

For more information on new products introduced at AACC, please visit Thermo Scientific booth 5140 or the online media room at www.thermofisher.com/news.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $13 billion, we have 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs